582 related articles for article (PubMed ID: 34470186)
1. Effectiveness of Medical Nutritional Therapy in the Management of Type 2 Diabetes Mellitus.
Varadaraj G; Sangeetha B; Nithiya DR; Dixit PK
J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470186
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial.
Franz MJ; Monk A; Barry B; McClain K; Weaver T; Cooper N; Upham P; Bergenstal R; Mazze RS
J Am Diet Assoc; 1995 Sep; 95(9):1009-17. PubMed ID: 7657902
[TBL] [Abstract][Full Text] [Related]
3. NIDDM: new once-daily intervention for type 2 diabetes mellitus: Diaprel MR.
Ionescu-Tîrgovişte C; Gavrilă L; Brădescu OM; Guja C
Rom J Intern Med; 2004; 42(2):431-40. PubMed ID: 15529633
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.
Marincic PZ; Salazar MV; Hardin A; Scott S; Fan SX; Gaillard PR; Wyatt C; Watson L; Green P; Glover P; Hand M
J Acad Nutr Diet; 2019 Mar; 119(3):449-463. PubMed ID: 30219311
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
7. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
8. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
9. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
10. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes.
Minari TP; Manzano CF; Tácito LHB; Yugar LBT; Sedenho-Prado LG; Rubio TA; Pires AC; Vilela-Martin JF; Cosenso-Martin LN; Moreno H; Yugar-Toledo JC
Nutrients; 2024 May; 16(9):. PubMed ID: 38732624
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
12. The effect of medical nutrition therapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial.
Parker AR; Byham-Gray L; Denmark R; Winkle PJ
J Acad Nutr Diet; 2014 Nov; 114(11):1739-48. PubMed ID: 25218597
[TBL] [Abstract][Full Text] [Related]
13. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes.
Stringer F; DeJongh J; Enya K; Koumura E; Danhof M; Kaku K
Diabetes Technol Ther; 2015 Mar; 17(3):215-23. PubMed ID: 25531677
[TBL] [Abstract][Full Text] [Related]
15. Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.
Goldstein BJ; Rosenstock J; Anzalone D; Tou C; Ohman KP
Curr Med Res Opin; 2006 Dec; 22(12):2575-90. PubMed ID: 17166340
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum glycosylated hemoglobin and fasting plasma glucose predicts gestational diabetes at the first trimester in Turkish women with a low-risk pregnancy and its relationship with fetal birth weight; a retrospective cohort study.
Kansu-Celik H; Ozgu-Erdinc AS; Kisa B; Eldem S; Hancerliogullari N; Engin-Ustun Y
J Matern Fetal Neonatal Med; 2021 Jun; 34(12):1970-1977. PubMed ID: 31370710
[TBL] [Abstract][Full Text] [Related]
17. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
Sharma SK; Verma SH
J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose.
Thamakaison S; Anothaisintawee T; Sukhato K; Unwanatham N; Rattanasiri S; Reutrakul S; Thakkinstian A
BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34845059
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose.
Kasthuri S; Poongothai S; Anjana RM; Selvakumar J; Muthukumar S; Kayalvizhi S; Tariq S; Honey E; Gupta PK; Venkatesan U; Mohan V
Diabetes Technol Ther; 2021 Mar; 23(3):213-220. PubMed ID: 32916063
[No Abstract] [Full Text] [Related]
20. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
